Quantum evaluation and therapeutic activity of (E)-N-(4-methoxyphenyl)-2-(4-(3-oxo-3-phenylprop-1-en-1-yl) phenoxy)acetamide and its modified derivatives against EGFR and VEGFR-2 in the treatment of triple-negative cancer via in silico approach-Reference-Cited by-同舟云学术

Quantum evaluation and therapeutic activity of (E)-N-(4-methoxyphenyl)-2-(4-(3-oxo-3-phenylprop-1-en-1-yl) phenoxy)acetamide and its modified derivatives against EGFR and VEGFR-2 in the treatment of triple-negative cancer via in silico approach

Published:2023-04-26 Issue:5 Volume:29 Page:
ISSN:1610-2940
Container-title:Journal of Molecular Modeling
language:en
Short-container-title:J Mol Model

Author:

Ipinloju Nureni,Ibrahim Abdulwasiu,da Costa Renato Araujo,Adigun Tawakalit Boluwatife,Olubode Samuel Olawale,Abayomi Kehinde Joan,Aiyelabegan Abdulsamad Omotayo,Esan Timothy Oluwaseun,Muhammad Suleiman Alhaji,Oyeneyin Oluwatoba Emmanuel

Publisher

Springer Science and Business Media LLC

Subject

Computational Theory and Mathematics,Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Catalysis

Link

https://link.springer.com/content/pdf/10.1007/s00894-023-05543-2.pdf

Reference75 articles.

1. Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M, Sinha N (2015) Therapeutic targets of triple-negative breast cancer: a review. Br J Pharmacol 172(17):4228–4237

2. Reis-Filho J, Tutt A (2008) Triple negative tumours: a critical review. Histopathology 52(1):108–118

3. Nakai K, Hung MC, Yamaguchi H (2016) A perspective on anti-EGFR therapies targeting triple-negative breast cancer. Am J Cancer Res 6(8):1609

4. Nascimento C, Gameiro A, Ferreira J, Correia J, Ferreira F (2021) Diagnostic value of VEGF-A, VEGFR-1 and VEGFR-2 in feline mammary carcinoma. Cancers 13(1):117

5. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13(1):9–22

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Investigation of Polo-like Kinase 1 (plk1): Inhibitive Potential of Benzimidazole-Carbonamide Derivatives for Cancer Treatment;PHYS CHEM RES;2024

2. Computational identification of potential acetylcholinesterase (AChE) and monoamine oxidase-B inhibitors from Vitis vinifera: a case study of Alzheimer’s disease (AD);In Silico Pharmacology;2024-05-31

3. In Silico Repurposing of a Novel Inhibitor (drug) of EGFR and VEGFR-2 Kinases of Cancer by Pharmacokinetics, Toxicity, Molecular Docking, and Molecular Dynamics Simulation;Applied Biochemistry and Biotechnology;2024-05-24

4. Recent development of VEGFR small molecule inhibitors as anticancer agents: A patent review (2021–2023);Bioorganic Chemistry;2024-05

5. Computational identification of potential modulators of heme-regulated inhibitor (HRI) for pharmacological intervention against sickle cell disease;Journal of Biomolecular Structure and Dynamics;2024-03-31